SW
Stephen Andrew Welch
EVP & Head of Spec Generics

Stephen Andrew Welch insider trades: Mallinckrodt (MNK) stock purchases

EVP & Head of Spec Generics, Mallinckrodt Last trade Mar 13, 2023 10 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
1
Open-market trades
since 2023
3
Companies
last trade 2023

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stephen reports to the SEC

Open-market buys and sales

1 trade reported on SEC Form 4, newest first

DateStockTypeValue
Mar 13, 2023MNK↑ Buy$8K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Stephen Andrew Welch's insider trades

Stephen Andrew Welch is EVP & Head of Spec Generics at Mallinckrodt (MNK). Since Mar 13, 2023, Stephen has reported 1 open-market purchase worth $8K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (4 filings), shares returned to the company (3 filings), shares withheld for taxes (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MNK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.